1. Search Result
Search Result
No matches for "

29965

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

13

Inhibitors & Agonists

2

Isotope-Labeled Compounds

7

Antibodies

2

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0139
    Flucytosine
    3 Publications Verification

    5-Fluorocytosine; NSC 103805; Ro 2-9915

    Fungal Antibiotic Infection Cancer
    Flucytosine (5-Fluorocytosine) is an antifungal compound with oral activity. Flucytosine is a widely used cytotoxic drug that, after further metabolism, produces fluorinated ribonucleotides and deoxyribonucleotides, inhibits DNA and protein synthesis, and has multiple effects such as inhibiting candida and candida neoplasm infection and producies cytotoxicity to cancer cells .
    Flucytosine
  • HY-B0435
    Roxithromycin
    Maximum Cited Publications
    7 Publications Verification

    RU-28965

    Bacterial Antibiotic Apoptosis p38 MAPK NF-κB Infection Cardiovascular Disease Inflammation/Immunology Cancer
    Roxithromycin (RU-28965) is an orally active semi-synthethic macrolide antibiotic. Roxithromycin inhibits protein biosynthesis in the elongation step by binding to 50S bacterial ribosome. Roxithromycin has antimicrobial, antiproliferative, anti-inflammatory, tumour vasculature inhibiting and lung injury ameliorating effects .
    Roxithromycin
  • HY-116578
    Metopimazine
    3 Publications Verification

    EXP999; RP9965

    Dopamine Receptor Neurological Disease
    Metopimazine (EXP999; RP9965) is a phenothiazine, orally available, selective dopamine D2 receptor antagonist that does not penetrate the blood-brain barrier. Metopimazine blocks dopamine D2 receptors in the chemoreceptor trigger zone and the periphery, thereby inhibiting nausea and vomiting. Metopimazine is indicated for chemotherapy-induced nausea and vomiting, and has low central side effects due to its poor brain penetration. The use of metopimazine in acute gastroenteritis may have potential risks .
    Metopimazine
  • HY-B0435S

    RU-28965-d7

    Isotope-Labeled Compounds Antibiotic Bacterial Others
    Roxithromycin-d7 (RU-28965-d7) is the deuterium labeled Roxithromycin (HY-B0435) . Roxithromycin (RU-28965) is a semi-synthetic macrolide antibiotic .
    Roxithromycin-d7
  • HY-B0139R

    5-Fluorocytosine (Standard); NSC 103805 (Standard); Ro 2-9915 (Standard)

    Reference Standards Fungal Antibiotic Infection Cancer
    Flucytosine (Standard) is the analytical standard of Flucytosine. This product is intended for research and analytical applications. Flucytosine (5-Fluorocytosine) is an antifungal compound with oral activity. Flucytosine is a widely used cytotoxic drug that, after further metabolism, produces fluorinated ribonucleotides and deoxyribonucleotides, inhibits DNA and protein synthesis, and has multiple effects such as inhibiting candida and candida neoplasm infection and producies cytotoxicity to cancer cells .
    Flucytosine (Standard)
  • HY-B0435R

    RU-28965 (Standard)

    Reference Standards Bacterial Antibiotic Infection
    Roxithromycin (Standard) is the analytical standard of Roxithromycin. This product is intended for research and analytical applications. Roxithromycin (RU-28965) is a semi-synthetic macrolide antibiotic.
    Roxithromycin (Standard)
  • HY-156458

    REV-ERB Inflammation/Immunology
    SR-29065 is a selective REV-ERBα agonist, can be used for autoimmune disorders research .
    SR-29065
  • HY-177618A

    SPC2996 sodium

    Bcl-2 Family Cancer
    Beclanorsen sodium is an antisense oligonucleotide targeted to the mRNA of the Bcl-2 oncoprotein.
    Beclanorsen sodium
  • HY-177618

    SPC2996

    Bcl-2 Family Cancer
    Beclanorsen is an antisense oligonucleotide targeted to the mRNA of the Bcl-2 oncoprotein.
    Beclanorsen
  • HY-149686

    Drug Derivative Others
    WAY-299765 is an active molecule.
    WAY-299765
  • HY-116578R

    EXP999 (Standard); RP9965 (Standard)

    Drug Derivative Reference Standards Inflammation/Immunology
    Metopimazine (Standard) is the analytical standard of Metopimazine. This product is intended for research and analytical applications. Metopimazine (EXP999) is a phenothiazine derivative used to prevent emesis during chemotherapy. Metopimazine belongs to the anti-dopaminergic anti-emetics (ADA) class. Metopimazine can be used for the research of gastroenteritis (GE) .
    Metopimazine (Standard)
  • HY-116578S

    EXP999-d6; RP9965-d6

    Isotope-Labeled Compounds Dopamine Receptor Neurological Disease
    Metopimazine-d6 (EXP999-d6; RP9965-d6) is the deuterium labeled Metopimazine (HY-116578). Metopimazine (EXP999; RP9965) is a phenothiazine, orally available, selective dopamine D2 receptor antagonist that does not penetrate the blood-brain barrier. Metopimazine blocks dopamine D2 receptors in the chemoreceptor trigger zone and the periphery, thereby inhibiting nausea and vomiting. Metopimazine is indicated for chemotherapy-induced nausea and vomiting, and has low central side effects due to its poor brain penetration. The use of metopimazine in acute gastroenteritis may have potential risks .
    Metopimazine-d6
  • HY-156458A

    REV-ERB Inflammation/Immunology
    (R)-SR-29065 is a selective REV-ERBα inhibitor with a IC50 of 10 nM. (R)-SR-29065 is applicable to research related to autoimmune diseases .
    (R)-SR-29065

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation: * Country or Region:
* Applicant Name: * Organization Name:
* Department:    
* Email Address: * Product Name:
Cat. No.: * Requested quantity:
* Phone Number:    
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: